Latest Issues

view more
February 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

February 2025 - Pharmaceutical Market Europe

Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in clinical trials

January 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

January 2025 - Pharmaceutical Market Europe

Avalere Health’s Amar Urhekar on his career path; Insights from ASH 2024; The science behind gene-silencing technology

December 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

December 2024 - Pharmaceutical Market Europe

Sanofi’s John Forni on the escalating challenges of treating COPD; The need for a human touch in an AI world; PMGroup celebrates the 24th PMEAs!

November 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

November 2024 - Pharmaceutical Market Europe

The explosive growth of Gen AI; Liberating patient pathways; Closing health equity gaps

October 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

October 2024 - Pharmaceutical Market Europe

Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024

September 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

September 2024 - Pharmaceutical Market Europe

The challenges of environmental sustainability; ‘Causes That Count, Health’ report; Rethinking neurodegeneration

July/August 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

July/August 2024 - Pharmaceutical Market Europe

Merck’s Doina Ionescu on her professional journey; Full coverage of Communiqué 2024; Omnichannel opportunities

June 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

June 2024 - Pharmaceutical Market Europe

GSK’s Jack Harris on innovation in oncology; Harnessing creativity in a digital age; Sustainability in pharma

May 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

May 2024 - Pharmaceutical Market Europe

Interview with Ipsen’s Ioana Parsons on her new role; Celebrating comms excellence; Getting trial diversity right

April 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

April 2024 - Pharmaceutical Market Europe

Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change

March 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

March 2024 - Pharmaceutical Market Europe

Interview with Sanofi’s Rippon Ubhi on her new role; Optimising MS care and patient outcomes; Overcoming pharma web strategy challenges

Feb 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

Feb 2024 - Pharmaceutical Market Europe

Diversity, equity and inclusion in medical research; Marking International Day of Women and Girls in Science; Incentivising innovation in antibiotics

Jan 2024 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

Jan 2024 - Pharmaceutical Market Europe

Interview with AstraZeneca’s Ed Piper on patient outcomes; Pharma trends and predictions for 2024; Precision medicine in chronic diseases

Thought Leadership

view more
article-category

PATIENT INCLUSIVITY - Inclusivity, collaboration and targeted care

CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value

Thought Leadership, 20 February 2025
article-category

TL ICON - Standing out in a crowded precision oncology landscape

What value does your strategic planning add?

Thought Leadership, 20 February 2025
article-category

MARKETING OBJECTIVES - Setting your sights – the marketing objectives

Thought Leadership, 20 February 2025
article-category

ASH 2024 - Keto, CAR-T and creativity: insights from ASH 2024

CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value

Thought Leadership, 22 January 2025
article-category

TL Inizio - Communicating AI in healthcare: a guide for effective strategy

What value does your strategic planning add?

Thought Leadership, 22 January 2025
article-category

AI AND PHARMA MARKETING - RThe AI tipping point in pharma marketing: balancing technology and trust

Thought Leadership, 22 January 2025

News & Columns

view more
article-category

News

Roche and Ascidian agree to $1.8bn neurological disease partnership

article-category

News

Researchers identify new major cause of inflammatory bowel disease

article-category

Dermatology News

UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa

article-category

DARWIN'S MEDICINE - Astrategia

The evolutionary lessons for Bayer’s management restructure

article-category

MIKE DIXON - What is it all for?

Collecting the right data in the right way for the right reasons

article-category

INNOVATIVE IMPACT BLOG - The full potential of patient journeys in pharma

How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?

article-category

HEALTHCARE COMMUNICATIONS - Using impact to show accountability and progress'

article-category

News

Roche and Ascidian agree to $1.8bn neurological disease partnership

article-category

News

Researchers identify new major cause of inflammatory bowel disease

article-category

Dermatology News

UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa

article-category

DARWIN'S MEDICINE - Promiscuous strategists

The evolutionary lessons for Bayer’s management restructure

article-category

MIKE DIXON - Back to work

Collecting the right data in the right way for the right reasons

article-category

INNOVATIVE IMPACT BLOG - Shaping the future of pharma with human-centric transformation techniques

How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?

article-category

HEALTHCARE - Celebrating collective achievement – the power of collaboration

article-category

News

Roche and Ascidian agree to $1.8bn neurological disease partnership

article-category

News

Researchers identify new major cause of inflammatory bowel disease

Features

view more
article-category

PHARMACOVIGILANCE - Why local knowledge is key to global pharmacovigilance outcomes

Across almost every sector, brands are multiplying their investment in creativity

Features, 20 February 2025
article-category

MARKET TRENDS - Key clinical trial trends – EU vs US perspectives

Picking your omnichannel direction requires a disciplined, scientific approach

Features, 20 February 2025
article-category

NEWS - RARE DISEASE DAY

Ethical content sharing and the benefits of the CLA Pharmaceutical Licence

Features, 20 February 2025
article-category

AMAR URHEKAR AVALERE HEALTH - The power of purpose

Across almost every sector, brands are multiplying their investment in creativity

Features, 22 January 2025
article-category

BIOTECH SPIN-OUTS - Creating and sustaining university biotech spin-outs

Picking your omnichannel direction requires a disciplined, scientific approach

Features, 22 January 2025
article-category

GENE-SILENCING TECHNOLOGY - The silent treatment – researching gene silencing for Alzheimer’s, Parki

Ethical content sharing and the benefits of the CLA Pharmaceutical Licence

Features, 22 January 2025

Communiqué - Marketing & Comms

view more
article-category

BIOTECH SPIN-OUTS – A PRACTICAL GUIDE - Preparing biotechs for spin-out and beyond

‘Patient engagement is both a process and a behaviour throughout the drug life cycle’

Communique - Marketing & Comms, 20 February 2025
article-category

HEALTHCARE COMMS

Communique - Marketing & Comms, 20 February 2025
article-category

GENAI AND HEALTHCARE - GenAI and healthcare – potential that goes beyond established technologies

‘Patient engagement is both a process and a behaviour throughout the drug life cycle’

Communique - Marketing & Comms, 22 January 2025
article-category

AI AND THE HUMAN VOICE - The need for a human touch in an AI world

Communique - Marketing & Comms, 22 January 2025
article-category

HEALTHCARE COMMS

Communique - Marketing & Comms, 22 January 2025
article-category

AI AND THE HUMAN VOICE - The need for a human touch in an AI world

Communique - Marketing & Comms, 16 December 2024

Careers & Recruitment

view more
article-category

Appointments

Appointments & Recruitment, 20 February 2025
article-category

Appointments

Appointments & Recruitment, 20 February 2025
article-category

Appointments

Appointments & Recruitment, 22 January 2025
article-category

Appointments

Appointments & Recruitment, 22 January 2025
article-category

Appointments

Appointments & Recruitment, 16 December 2024
article-category

Appointments

Appointments & Recruitment, 16 December 2024

PME Supplements

view more
DIVERSITY, EQUITY AND INCLUSION - PME Supplement March 2022

DIVERSITY, EQUITY AND INCLUSION - PME Supplement March 2022

DIVERSITY, EQUITY AND INCLUSION - A diverse, equitable and inclusive organisation performs better as it can engage with diverse communities, and catalyse greater creativity and innovation

Amarin - October 2021 PME Supplement

Amarin - October 2021 PME Supplement

Amarin Supplement with October 2021 PME Amarin in Europe - Rethinking Cardiovascular Risk, Transforming the CVD Treatment Paradigm in Europe, Delivering Launch Excellence Across Europe, Pharma Marketing Challenges During a Pandemic

How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020

How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020

As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate. This supplement looks at how these innovations can help HCPs in the fight against COVID-19.

DIGITAL, DOCTORS AND PATIENTS - PME Supplement March 2020

DIGITAL, DOCTORS AND PATIENTS - PME Supplement March 2020

DIGITAL, DOCTORS AND PATIENTS - Key emerging trends in digital health. Current and future trends for developing digital medical communications: Evolving digital trends and user needs. Key emerging trends in digital health: Improving healthcare for patients and helping doctors to be more efficient

PATIENT ENGAGEMENT - PME Supplement - September 2019

PATIENT ENGAGEMENT - PME Supplement - September 2019

PATIENT ENGAGEMENT - PME September 2019 Supplement - The business case for patient engagement: using digital to bridge the engagement gap between patients and pharma. Understanding the patient journey: what can we learn from customer service. How technology is driving new trends in patient engagement.

How to Install